Table of Content

1 Study Coverage
1.1 Restless Legs Syndrome Product Introduction
1.2 Market by Type
1.2.1 Global Restless Legs Syndrome Market Size Growth Rate by Type, 2018 VS 2023 VS 2029
1.3 Market by Application
1.3.1 Global Restless Legs Syndrome Market Size Growth Rate by Application, 2018 VS 2023 VS 2029
1.4 Global Restless Legs Syndrome Market by Region
1.4.1 Global Restless Legs Syndrome Market by Region: 2018 VS 2023 VS 2029
1.4.2 Global Restless Legs Syndrome Revenue Market
1.5 Study Objectives
1.6 Years Considered
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease (COVID-19) Impact on Global
2 Competition by Players
2.1 Global Restless Legs Syndrome Revenue by Players
2.1.1 Global Restless Legs Syndrome Revenue by Players (2018-2023)
2.1.2 Global Restless Legs Syndrome Revenue Market Share by Players (2018-2023)
2.1.3 Global Top 5 and Top 10 Companies by Restless Legs Syndrome Revenue in 2023
2.2 Global Restless Legs Syndrome Gross Margin by Players
2.3 Analysis of Competitive Landscape
2.3.1 Players Market Concentration Ratio (CR5)
2.3.2 Global Restless Legs Syndrome Players Geographical Distribution
2.4 Mergers & Acquisitions, Expansion Plans
3 Company Overview
3.1 Boehringer Ingelheim GmbH
3.1.1 Boehringer Ingelheim GmbH Information
3.1.2 Boehringer Ingelheim GmbH Overview
3.1.3 Boehringer Ingelheim GmbH Restless Legs Syndrome Revenue and Gross Margin (2018-2023)
3.1.4 Boehringer Ingelheim GmbH Related Developments
3.2 UCB SA
3.2.1 UCB SA Information
3.2.2 UCB SA Overview
3.2.3 UCB SA Restless Legs Syndrome Revenue and Gross Margin (2018-2023)
3.2.4 UCB SA Related Developments
3.3 Astellas
3.3.1 Astellas Information
3.3.2 Astellas Overview
3.3.3 Astellas Restless Legs Syndrome Revenue and Gross Margin (2018-2023)
3.3.4 Astellas Related Developments
3.4 Arbor Pharmaceuticals
3.4.1 Arbor Pharmaceuticals Information
3.4.2 Arbor Pharmaceuticals Overview
3.4.3 Arbor Pharmaceuticals Restless Legs Syndrome Revenue and Gross Margin (2018-2023)
3.4.4 Arbor Pharmaceuticals Related Developments
3.5 GlaxoSmithKline plc.
3.5.1 GlaxoSmithKline plc. Information
3.5.2 GlaxoSmithKline plc. Overview
3.5.3 GlaxoSmithKline plc. Restless Legs Syndrome Revenue and Gross Margin (2018-2023)
3.5.4 GlaxoSmithKline plc. Related Developments
3.6 Ligand Pharmaceuticals Incorporated
3.6.1 Ligand Pharmaceuticals Incorporated Information
3.6.2 Ligand Pharmaceuticals Incorporated Overview
3.6.3 Ligand Pharmaceuticals Incorporated Restless Legs Syndrome Revenue and Gross Margin (2018-2023)
3.6.4 Ligand Pharmaceuticals Incorporated Related Developments
3.7 axxonis Pharma AG
3.7.1 axxonis Pharma AG Information
3.7.2 axxonis Pharma AG Overview
3.7.3 axxonis Pharma AG Restless Legs Syndrome Revenue and Gross Margin (2018-2023)
3.7.4 axxonis Pharma AG Related Developments
3.8 Kyowa Hakko Kirin Co.
3.8.1 Kyowa Hakko Kirin Co. Information
3.8.2 Kyowa Hakko Kirin Co. Overview
3.8.3 Kyowa Hakko Kirin Co. Restless Legs Syndrome Revenue and Gross Margin (2018-2023)
3.8.4 Kyowa Hakko Kirin Co. Related Developments
3.9 Jazz Pharmaceuticals, Inc.
3.9.1 Jazz Pharmaceuticals, Inc. Information
3.9.2 Jazz Pharmaceuticals, Inc. Overview
3.9.3 Jazz Pharmaceuticals, Inc. Restless Legs Syndrome Revenue and Gross Margin (2018-2023)
3.9.4 Jazz Pharmaceuticals, Inc. Related Developments
3.10 Omeros Corporation
3.10.1 Omeros Corporation Information
3.10.2 Omeros Corporation Overview
3.10.3 Omeros Corporation Restless Legs Syndrome Revenue and Gross Margin (2018-2023)
3.10.4 Omeros Corporation Related Developments
3.11 Manhattan Pharmaceuticals
3.11.1 Manhattan Pharmaceuticals Information
3.11.2 Manhattan Pharmaceuticals Overview
3.11.3 Manhattan Pharmaceuticals Restless Legs Syndrome Revenue and Gross Margin (2018-2023)
3.11.4 Manhattan Pharmaceuticals Related Developments
4 Market Size by Type
4.1 Global Restless Legs Syndrome Revenue by Type
4.2 Global Restless Legs Syndrome Market Size Growth by Type 2018-2023
5 Market Size by Application
5.1 Global Restless Legs Syndrome Revenue by Application
5.2 Global Restless Legs Syndrome Market Size Growth by Application 2018-2023
6 Global Restless Legs Syndrome Market Insights
6.1 Global Restless Legs Syndrome Market Revenue 2018-2023
6.2 Global Restless Legs Syndrome Revenue by Region
6.3 Americas
6.4 Europe
6.5 Asia-Pacific
6.6 Middle East & Africa
7 Americas
7.1 Americas Restless Legs Syndrome Market Size by Country
7.1.1 Americas Restless Legs Syndrome Revenue by Country (2018-2023)
7.1.2 U.S.
7.1.3 Canada
7.1.4 Mexico
7.1.5 Brazil
7.1.6 Argentina
8 Europe
8.1 Europe Restless Legs Syndrome Market Size by Country
8.1.1 Europe Restless Legs Syndrome Revenue by Country (2018-2023)
8.1.2 Germany
8.1.3 France
8.1.4 U.K.
8.1.5 Italy
8.1.6 Russia
9 Asia Pacific
9.1 Asia Pacific Restless Legs Syndrome Market Size by Region
9.1.1 Asia Pacific Restless Legs Syndrome Revenue by Region (2018-2023)
9.1.2 China
9.1.3 Japan
9.1.4 South Korea
9.1.5 India
9.1.6 Southeast Asia
9.1.7 Australia
10 Middle East and Africa
10.1 Middle East and Africa Restless Legs Syndrome Market Size by Country
10.1.1 Middle East and Africa Restless Legs Syndrome Revenue by Country (2018-2023)
10.1.2 Turkey
10.1.3 Saudi Arabia
10.1.4 U.A.E
11 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
11.1 Restless Legs Syndrome Industry Trends
11.2 Restless Legs Syndrome Market Drivers
11.3 Restless Legs Syndrome Market Challenges
11.4 Restless Legs Syndrome Market Restraints
12 Restless Legs Syndrome Forecasted Market Size by Type
12.1 Global Restless Legs Syndrome Forecasted Revenue by Type
12.2 Global Restless Legs Syndrome Forecasted Market Size Growth by Type 2023-2029
13 Restless Legs Syndrome Forecasted Market Size by Application
13.1 Global Restless Legs Syndrome Forecasted Revenue by Application
13.2 Global Restless Legs Syndrome Forecasted Market Size Growth by Application 2023-2029
14 Global Restless Legs Syndrome Market Forecasts
14.1 Global Restless Legs Syndrome Market Revenue Forecasts 2023-2029
14.2 Global Restless Legs Syndrome Forecasts Revenue by Region
14.3 Americas
14.3.1 Americas Restless Legs Syndrome Forecasts Revenue by Country (2018-2023)
14.4 Europe
14.4.1 Europe Restless Legs Syndrome Forecasts Revenue by Country (2018-2023)
14.5 Asia-Pacific
14.5.1 Asia Pacific Restless Legs Syndrome Forecasts Revenue by Country (2018-2023)
14.6 Middle East & Africa
14.6.1 Middle East and Africa Restless Legs Syndrome Forecasts Revenue by Country (2018-2023)
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology
16.1.1 Research Process
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Legal Disclaimer